150 related articles for article (PubMed ID: 11526538)
1. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
Donato MF; Arosio E; Del Ninno E; Ronchi G; Lampertico P; Morabito A; Balestrieri MR; Colombo M
Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
[TBL] [Abstract][Full Text] [Related]
2. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis.
Delhaye M; Louis H; Degraef C; Le Moine O; Devière J; Gulbis B; Jacobovitz D; Adler M; Galand P
Hepatology; 1996 May; 23(5):1003-11. PubMed ID: 8621125
[TBL] [Abstract][Full Text] [Related]
3. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
4. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
Lee RG; Tsamandas AC; Demetris AJ
Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
8. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.
Ng IO; Ng M; Fan ST
Am J Gastroenterol; 1997 Aug; 92(8):1355-8. PubMed ID: 9260806
[TBL] [Abstract][Full Text] [Related]
9. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
10. Etiology and clinical profile of hepatocellular carcinoma in Bangladesh.
Khan M; Haq SA; Ahmed N; Matin MA
Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):16-24. PubMed ID: 9363673
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C
Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis.
Borzio M; Trerè D; Borzio F; Ferrari AR; Bruno S; Roncalli M; Colloredo G; Leandro G; Oliveri F; Derenzini M
Mol Pathol; 1998 Apr; 51(2):96-101. PubMed ID: 9713593
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical identification of proliferative hepatocytes using monoclonal antibody to proliferating cell nuclear antigen (PCNA/cyclin). Comparison with immunocytochemical staining for DNA polymerase-alpha.
Kawakita N; Seki S; Yanai A; Sakaguchi H; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S14-20. PubMed ID: 1374217
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in Italian patients with cirrhosis.
Colombo M; de Franchis R; Del Ninno E; Sangiovanni A; De Fazio C; Tommasini M; Donato MF; Piva A; Di Carlo V; Dioguardi N
N Engl J Med; 1991 Sep; 325(10):675-80. PubMed ID: 1651452
[TBL] [Abstract][Full Text] [Related]
15. Caffeine clearance study in hepatocellular carcinoma.
Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
[TBL] [Abstract][Full Text] [Related]
17. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.
Zhao M; Zhang NX; Du ZY; Laissue JA; Zimmermann A
Histol Histopathol; 1994 Jan; 9(1):73-83. PubMed ID: 7911690
[TBL] [Abstract][Full Text] [Related]
18. [Screening for hepatocellular carcinoma in cirrhotic patients].
Beaugrand M
Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
[No Abstract] [Full Text] [Related]
19. [Analysis of nuclear DNA heterogeneity of the hepatocellular carcinoma (HCC)].
Horiuchi H; Yamashita Y; Kamachi M; Sendo S; Kobayashi K; Yanase Y; Nakamura Y; Kakegawa T; Nakashima T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():11-6. PubMed ID: 7515614
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis].
Elizalde JI; Castells A; Planas R; Rodríguez-Iglesias MP; Bruix J; Brú C; Saló J; Boix J; Gassull MA; Terés J; Rodés J
Gastroenterol Hepatol; 1996 Apr; 19(4):189-93. PubMed ID: 8665355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
